Brandon Guth, PA
Physician Assistant · Richmond, INNPI 1629587282
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $7,380 of the $11,190 with a category attached, or 66.0%. 27 manufacturers reported payments, led by AbbVie at 54.5% of the total. 2025 is the largest year on record at $5,456, more than ten times the $461 reported in 2021. Among physician assistant clinicians in IN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 529 payments — averaging $21.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$6K
- Lilly USA, LLC$686
- Novo Nordisk$668
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$524
- AstraZeneca$357
- Amgen$315
- plus $3K from 21 others
What the payments were for
- Speaking & faculty fees$3,75034%
- Food & beverage$7,38066%
- Education$591%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 195 | $6,098 |
| Lilly USA, LLC | 45 | $686 |
| Novo Nordisk | 46 | $668 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 35 | $524 |
| AstraZeneca | 19 | $357 |
| Amgen | 21 | $315 |
| Novartis | 16 | $303 |
| GSK | 18 | $273 |
| Boehringer Ingelheim | 15 | $220 |
| Abbott | 12 | $206 |
| Takeda Pharmaceuticals U.S.A., Inc. | 13 | $201 |
| Gilead | 10 | $183 |
| Lundbeck LLC | 18 | $183 |
| Axsome Therapeutics, Inc. | 8 | $167 |
| Vanda Pharmaceuticals Inc. | 14 | $141 |
| Pfizer | 7 | $103 |
| Indivior Inc. | 6 | $93 |
| Astellas Pharma US Inc | 4 | $89 |
| Exact Sciences | 5 | $78 |
| Corium, LLC | 4 | $69 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $56 |
| Otsuka America Pharmaceutical, Inc. | 3 | $54 |
| Phathom Pharmaceuticals, Inc. | 6 | $36 |
| Sanofi Pasteur Inc. | 2 | $30 |
| Bayer | 2 | $28 |
| Xeris Pharmaceuticals, Inc. | 1 | $15 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VRAYLAR$3,750
How this compares
$11,190 in reported general payments places this provider in the 95th percentile of 1,955 physician assistant providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 31 | $28,991 |
| RybelsusSemaglutide | 21 | $28,502 |
| JardianceEmpagliflozin | 25 | $27,033 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 32 | $25,424 |
| MounjaroTirzepatide | 17 | $21,654 |
| RexultiBrexpiprazole | 12 | $18,965 |
| TrintellixVortioxetine Hydrobromide | 19 | $16,828 |
| LinzessLinaclotide | 13 | $7,129 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 27 | $3,837 |
| Vilazodone Hcl | 12 | $1,922 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 11 | $1,559 |
| Duloxetine Hcl | 64 | $1,106 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 54 | $1,069 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 20 | $974 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 77 | $937 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus | $668 | $57,49352 claims |
| Boehringer IngelheimJardiance | $220 | $27,03325 claims |
| GSKTrelegy Ellipta | $273 | $25,42432 claims |
| Lilly USA, LLCMounjaro | $686 | $21,65417 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $54 | $18,96512 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $201 | $16,82819 claims |
| AbbVieLinzess | $6,098 | $7,12913 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,955 physician assistant providers in Indiana.
Other physician assistant in Richmond
- Kristen GumpfCarmel$142K
- Andrew NordIndianapolis$47K
- Qun Ming ZhangIndianapolis$28K
- Lauren HoweMunster$28K
- A FergusonFort Wayne$22K
- Jacquelyn BeemerFort Wayne$21K
- Lindsay YoderIndianapolis$21K
- Eryn GormanClinton$18K
- Audrey HewittBloomington$17K
- Mackenzie LawsonIndianapolis$15K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.